MARKET IS OPEN
Loading latest tickers...

Market Indices

S&P 500
$7,722.72
+0.73%
NASDAQ 100
$30,807.93
+1.00%
DOW JONES
$51,177.00
+0.49%
NASDAQ Composite
$27,190.86
+1.19%
RUSSELL 2000
$2,815.20
+0.90%
CBOE VIX
$15.31
-6.59%

Sector Heatmap

Technology+1.01%
Financials+0.06%
Healthcare-0.01%
Consumer Cycl+1.13%
Consumer Staples+0.25%
Energy+0.40%
Industrials+0.78%
Materials+0.66%
Real Estate+0.32%
Utilities+0.38%
Comm Services+0.35%

HBIO — Harvard Bioscience Inc

Nasdaq

Harvard Bioscience Inc

CompareBack to Screener
$8.34
+0.21(+2.58%)
O
8.08
H
8.42
L
8.03
V
15.44K
⏱️ End-of-day dataAs of Oct 2, 2026

Chart

About HBIO

Harvard Bioscience Inc is a developer, manufacturer, and seller of technologies, products, and services that enable advances in life science applications, including research, drug and therapy discovery, bioproduction, and preclinical testing. The company organizes its product line into two product families: Cellular and Molecular Technologies (CMT) and Preclinical. The CMT product family supports molecular, cellular, organ, and organoid research, as well as bioproduction and in vitro testing, while the Preclinical product family provides products for preclinical research and testing, including data collection and analysis for safety and regulatory compliance. Its geographical segments include the Americas, Europe, Middle East and Africa, and Asia.

IndustryLABORATORY ANALYTICAL INSTRUMENTS
SectorNot available
IPO DateDec 7, 2000
Employees339
Stock ExchangeNasdaq
Ticker SymbolHBIO

Key Financial Statistics

Market Cap$37.97M
P/E RatioN/A
Dividend YieldNone
EPSN/A
BetaN/A
52-Week Range$3.80 - $9.40
52-Week Avg Volume188.6K
VWAP$8.27
Transactions335
Total Recorded Bars6,423 days